← Open Payments lookup

SHERONA BAU: Open Payments

NPI 1902056062 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$12,891 in 43 payments from 10 companies in 2025. Trend: 2023 $3,766 · 2024 $12,361 · 2025 $12,891

Speaker / faculty: $4,710Consulting: $4,600Food & beverage: $2,119Travel & lodging: $1,462
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC13$4,158
Madrigal Pharmaceuticals7$3,526
Ipsen Biopharmaceuticals, Inc6$2,734
GlaxoSmithKline, LLC.1$1,350
Gilead Sciences, Inc.9$591
Alnylam Pharmaceuticals Inc.3$211
Mirum Pharmaceuticals, Inc.1$142
Novo Nordisk Inc1$125
ABBVIE INC.1$34
Intercept Pharmaceuticals, Inc.1$20

Products named: TRULANCE, REZDIFFRA, IQIRVO, GIVLAARI, Livmarli, Vemlidy, XIFAXAN, Wegovy.

Industry payments across CA — which companies pay providers there.